384 related articles for article (PubMed ID: 12813006)
1. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
2. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.
Suzuki A; Ito T; Imai E; Yamato M; Iwatani H; Kawachi H; Hori M
J Am Soc Nephrol; 2003 Apr; 14(4):981-91. PubMed ID: 12660332
[TBL] [Abstract][Full Text] [Related]
3. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
[TBL] [Abstract][Full Text] [Related]
5. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
7. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study.
Seçkin İ; Uzunalan M; Pekpak M; Köktürk S; Sönmez HA; Güngör ZB; Demirkiran ÖD; Saygi Hİ; Yaprak Saraç E
Rom J Morphol Embryol; 2017; 58(3):823-830. PubMed ID: 29250660
[TBL] [Abstract][Full Text] [Related]
8. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.
Petrovic-Djergovic D; Popovic M; Chittiprol S; Cortado H; Ransom RF; Partida-Sánchez S
Clin Exp Immunol; 2015 May; 180(2):305-15. PubMed ID: 25561167
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
11. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
Andrews PM
Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
Inokuchi S; Shirato I; Kobayashi N; Koide H; Tomino Y; Sakai T
Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
Pawluczyk IZ; Najafabadi MG; Brown JR; Bevington A; Topham PS
Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
Fernandez L; Romero M; Rincón J; Mosquera J
Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
[TBL] [Abstract][Full Text] [Related]
15. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
[TBL] [Abstract][Full Text] [Related]
16. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
18. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
20. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis.
Ryan GB; Rodewald R; Karnovsky MJ
Lab Invest; 1975 Nov; 33(5):461-8. PubMed ID: 1186127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
